Fosun International LTD Gilead Sciences, Inc. Transaction History

Fosun International LTD

$106 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$57.72 - $65.01 $432,900 - $487,575	-7,500 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $142,736 - $162,008	-2,200 Reduced 22.68%	7,500 $552,000
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $2.24 Million - $2.42 Million	-33,098 Reduced 77.34%	9,700 $688,000
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $4.44 Million - $4.85 Million	-70,000 Reduced 62.06%	42,798 $2.94 Million
Q1 2021 May 11, 2021	BUY	$60.0 - $68.46 $803,700 - $917,021	13,395 Added 13.48%	112,798 $7.36 Million
Q4 2020 Feb 05, 2021	BUY	$56.65 - $64.55 $708,125 - $806,875	12,500 Added 14.38%	99,403 $5.7 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $92,839 - $116,729	-1,495 Reduced 1.69%	86,903 $5.43 Million
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $12.9 Million - $14.9 Million	-177,889 Reduced 66.8%	88,398 $6.71 Million
Q1 2020 May 11, 2020	SELL	$62.63 - $80.22 $3.84 Million - $4.92 Million	-61,386 Reduced 18.73%	266,287 $20 Million
Q4 2019 Feb 18, 2020	SELL	$61.62 - $67.78 $698,154 - $767,947	-11,330 Reduced 3.34%	327,673 $21.3 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $4.12 Million - $4.55 Million	-65,970 Reduced 16.29%	339,003 $21.5 Million
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $527,751 - $591,811	8,530 Added 2.15%	404,973 $27.3 Million
Q1 2019 May 10, 2019	SELL	$62.53 - $70.05 $3.36 Million - $3.76 Million	-53,718 Reduced 11.93%	396,443 $25.6 Million
Q4 2018 Jan 31, 2019	SELL	$60.54 - $79.0 $9.2 Million - $12 Million	-151,961 Reduced 25.24%	450,161 $28.2 Million
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $4.88 Million - $5.4 Million	68,400 Added 12.82%	602,122 $46.4 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $12 Million - $14 Million	185,500 Added 53.27%	533,722 $37.8 Million
Q1 2018 May 08, 2018	BUY	$72.84 - $88.8 $16.3 Million - $19.9 Million	224,463 Added 181.37%	348,222 $26.3 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $8.92 Million - $10.6 Million	123,759	123,759 $10 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fosun International LTD with notifications on news.

Account